Roche leaves Abbott in the dust when it comes to US approval times
The Swiss group has succeeded with its internally developed diagnostics, but buying in innovation has served Becton Dickinson well.
Congenica aims to turn data into information
Sequencing data is all well and good, but what does it mean?
Luck, strategy and FDA device approvals
Experience and high staff levels help companies negotiate FDA approval – but luck plays a part.
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.